Fimbriae-mediated host-pathogen cross-talk

Current Opinion in Microbiology

Volumn 1, Issue 1, 1998, Pages 75-81

  Abraham, Soman N ^a   Jonsson, Ann Beth ^b   Normark, Staffan ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ESCHERICHIA COLI; NEISSERIA;

ADHESIN;

ENTEROBACTER INFECTION; ESCHERICHIA COLI; FIMBRIA; HUMAN; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; NEISSERIA; NEISSERIA MENINGITIDIS; NEISSERIACEAE INFECTION; PATHOGENICITY; PHAGOCYTOSIS; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION; URINARY TRACT;

ADHESINS, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FIMBRIAE, BACTERIAL; HUMANS; NEISSERIA; NEISSERIA MENINGITIDIS; NEISSERIACEAE INFECTIONS; PHAGOCYTOSIS; SIGNAL TRANSDUCTION; URINARY TRACT;

EID: 0031987918     PISSN: 13695274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1369-5274(98)80145-8     Document Type: Article

References (45)

1. Hagberg L, Jodal U, Korhonen TK, Svanborg CE: Adhesion hemagglutination and virulence of Escherichia coli causing urinary tract infections. Infect Immun 1981, 31:564-574.
2. Gander RM, Thomas VL: Distribution of type 1 and P pili on uropathogenic Escherichia coli O6. Infect Immun 1987, 55:293-297.
3. Lindberg F, Lund B, Johansson L, Normark S: Localization of the receptor-binding protein adhesin at the tip of the bacterial pilus. Nature 1987, 328:84-87.
4. Abraham SN, Sun D, Dale JB, Beachey EH: Conservation of the mannose-adhesin protein among type 1 fimbriated members of the family Enterobactericeae. Nature 1988, 336:682-684.
5. Kuehn MJ, Heuser J, Normark S, Hultgren SJ: P pili in uropathogenic E. coli are composite fibres with distinct fibrillar adhesive tips. Nature 1992, 356:252-255.
6. Jones CH, Pinkner JS, Heuser J, Abraham SN, Hultgren SJ: Assembly of fibrillar structures on enterobacterial type 1 pili. Proc Natl Acad Sci USA 1995, 92:2081-2085.
7. Jonsson A-B, Nyberg G, Normark S: Phase variation of gonococcal pili by frame shift mutation in pilC, a novel gene for pilus assembly. EMBO J 1991, 10:477-488.
8. Nassif X, Beretti J-L, Lowy J, Stenberg P, O'Gaora P, Pfeifer P, Normark S, So M: Roles of pilin and PilC in adhesion of Neisseria meningitidis to human epithelial and endothelial cells. Proc Natl Acad Sci USA 1994, 91:3769-3773.
9. Rudel T, Scheuerpflug I, Meyer TF: Neisseria PilC protein identified as type 4 pilus tip-located adhesin. Nature 1995, 373:357-359.
10. Rahman M, Källström H, Normark S, Jonsson A-B: PilC of pathogenic Neisseria is associated with the bacterial cell surface. Mol Microbiol 1997, 25:11-25. Direct evidence is presented that PilC in N. meningitidis is associated with the bacterial cell surface and that it is associated with pilus-mediated adherence. Interestingly, PilC is present in the membranes of both piliated and nonpiliated bacteria.
11. Källström H, Liszewski K, Atkinson JP, Jonsson A-B: Membrane cofactor protein (MCP or CD46) is a cellular pilus receptor for pathogenic Neisseria. Mol Microbiol 1997, 12:639-647. Very convincing evidence is presented demonstrating that CD46 is the receptor on human epithelial cells for type IV pili of both N. gonorrheae and N. meningitidis, CD46 is a human C3b/C4b binding glycoprotein involved in complement regulation on host cells. Neisseria appear to be coopting a physiologically important host molecule to promote its virulence.
12. Zhang JP, Normark S: Induction of gene expression in Escherichia coli after pilus-mediated adherence. Science 1996, 273:1234-1236. This is the first definitive indication that bacterial fimbriae can serve as sensory organelles.
13. Cotter PA, Miller JF: Triggering bacterial virulence. Science 1996, 273:1183-1184.
14. Frost LS, Finlay BB, Opgenorth A, Paranchych W, Lee JS: Characterization and sequence analysis of pilin from F-like plasmids. J Bacteriol 1985, 164:1238-1247.
15. Finlay BB, Cossart P: Exploitation of mammalian host cell functions by bacterial pathogens. Science 1997, 276:718-725. An excellent review of how certain host cell functions such as signal transduction pathways, cytoskeletal rearrangements, and vacuolar trafficking are exploited by bacteria to foster the disease process.
16. Finlay BB, Falkow S: Common themes in microbial pathogenicity revisited. Microbiol Mol Biol Rev 1997, 61:136-169. A good but somewhat exhaustive review which examines common strategies employed by various bacteria to further bacterial virulence in the host.
17. Zafriri D, Oron Y, Eisenstein BI, Ofek I: Growth advantage and enhanced toxicity of Escherichia coli adherent to tissue culture cells due to restricted diffusion of products secreted by the cells. J Clin Invest 1987, 79:1210-1216.
18. Svanborg C, Hedlund M, Connell H, Nilsson A, Wullt B: Bacterial adherence and mucosal cytokine responses. Receptors and transmembrane signaling. Ann NY Acad Sci 1996, 797:177-190. A good review of certain intracellular events associated with the cytokine response of uroepithelial cells following adherence of P-fimbriated E. coli.
19. Hedlund M, Svensson M, Nilsson A, Duan RD, Svanborg C: Role of the ceramide-signaling pathway in cytokine responses to P-fimbriated Escherichia coli. J Exp Med 1996, 183:1037-1044. First clues are provided to the underlying signaling events triggered in the host cell following the coupling of PapG adhesin of P fimbriae and its complementary cellular globoseries receptor.
20. Henderson B, Poole S, Wilson M: Bacterial modulins: a novel class of virulence factors which cause host tissue pathology by inducing cytokine synthesis. Microbiol Rev 1996, 60:316-341. A provocative review which proposes that bacterial cytokine-inducing molecules be considered a new class of virulence factors.
21. Wu XR, Sun TT, Medina JJ: In vitro binding of type 1-fimbriated Escherichia coli to uroplakins 1a. Proc Natl Acad Sci USA 1996, 93:9630-9635. Evidence is presented that the putative receptor on uroepithelial cells for the FimH adhesin of type 1 fimbriae is uroplakin-1, a major component of the apical surface of the epithelial cell.
22. Malaviya R, Ross E, MacGregor JI, Ikeda T, Little JR, Jakschick BA, Abraham SN: Mast cell phagocytosis of FimH-expressing enterobacteria. J Immunol 1994, 152:1907-1914.
23. Tewari R, MacGregor JI, Ikeda T, Little JR, Hultgren SJ, Abraham SN: Neutrophil activation by nascent FimH subunits of type 1 fimbriae purified from the periplasm of Escherichia coli. J Biol Chem 1993, 268:3009-3015.
24. Ponniah S, Abraham SN, Endres RO: T-cell-independent stimulation of immunoglobulin secretion in resting human B lymphocytes by the mannose-specific adhesin of Escherichia coli type 1 fimbriae. Infect Immun 1992, 60:5197-5203.
25. Gbarah A, Gahmberg CG, Ofek I, Jacobi U, Sharon N: Identification of the leukocyte adhesion molecules CD11 and CD18 as receptors for type 1 -fimbriated (mannose-specific) Escherichia coli. Infect Immun 1991, 59:4524-4530.
26. Sauter SL, Rutherfurd SM, Wagener C, Shively JE, Hefta SA: Identification of the specific oligosaccharide sites recognized by type 1 fimbriae from Escherichia coli on nonspecific cross-reacting antigen, a CD66 cluster granulocyte glycoprotein. J Biol Chem 1993, 268:15510-15516.
27. Baorto DM, Gao Z, Malaviya R, Dustin M, Van der Merwe A, Lublin D, Abraham SN: Survival of FimH-expressing enterobacteria in macrophages relies on glycolipid. Nature 1997, 389:636-639. This report indicates that, in the absence of serum components, phagocytosis of type 1 fimbriated E. coli by macrophages does not result in bacterial death. Evidence for an intracellular phagocytosis pathway is presented which is distinct from the classical phagosome-lysosome pathway utilized by the opsonophagocytic pathway.
28. Svanborg Eden C, Bjursten LM, Hull R, Hull S, Magnusson KE, Moldovano Z, Leffler H: Influence of adhesins on the interaction of Escherichia coli with human phagocytes. Infect Immun 1984, 44:672-680.
29. Tewari R, MacGregor JI, ikeda T, Little JR, Malaviya R, Hultgren SJ, Abraham SN: Negatively charged PapG fimbrial protein protects Escherichia coli against neutrophils. Infect Immun 1994, 62:5296-5304.
30. Malaviya R, Ikeda T, Ross E, Abraham SN: Mast cells modulate neutrophil influx and bacterial clearance at sites of infection through TNF alpha. Nature 1996, 381:77-80. This is one of the first demonstrations in vivo of the antibacterial role of mast cells. In addition, the capacity of FimH to stimulate a neutrophil influx in vivo is demonstrated.
31. Janmey PA: Phosphoinosides and calcium as regulators of cellular actin assembly and disassembly. Annu Rev Physiol 1994, 56:169-191.
32. Jaconi MEE, Lew DP, Carpenter JL, Magnusson K-E, Sjogren M, Stendahl O: Cytosolic free calcium elevation mediates the phagosome-lysosome fusion during phagocytosis in human neutrophils. J Cell Biol 1990, 119:1155-1564.
33. Ofek I, Goldhar J, Keisari Y, Sharon N: Nonopsonic phagocytosis of microorganisms. Annu Rev Microbiol 1995, 49:239-246.
34. Ulevitch RJ, Tobias PS: Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Annu Rev Immun 1995, 13:437-457.
35. Karnauchow TM, Toison DL, Harrison BA, Altman E, Lublin DM, Dimock K: The HeLa cell receptor for enterovirus 70 is decay-accelerating factor (CD55). J Virol 1996, 70:5143-5152.
36. Pham T, Kaul A, Hart A, Goluszko P, Moulds J, Nowicki S, Lublin DM, Nowicki BJ: dra-related X adhesins of gestational pyelonephritis-associated Escherichia coli recognize SCR-3 and SCR-4 domains of recombinant decay-accelerating factor. Infect Immun 1995, 63:1663-1668.
37. Zhu Z, Hao Y, Gershon MD, Ambron RT, Gershon AA: Targeting of glycoprotein I (gE) of varicella-zoster virus to the transGolgi network by an AYRV sequence and an acidic amino acid-rich patch in the cytosolic domain of the molecule. J Virol 1996, 70:6563-6575.
38. Solomon KR, Rudd CE, Finberg RW: The association between glycosylphosphatidylinositol-anchored proteins and heterotrimeric G protein alpha subunits in lymphocytes. Proc Natl Acad Sci USA 1996, 93:6053-6058. This paper suggests a mechanism by which glycosylphosphatidylinositol-anchored molecules, which do not span the membrane but are cell surface proteins, can transduce signals to the cell.
39. Liu J, Oh P, Horner T, Rogers RA, Schnitzer JE: Organized endothelial cell surface signal transduction in caveolae distinct from glycosylphosphatidylinositol-anchored protein microdomains. J Biol Chem 1997, 272:7211-7222.
40. Parton RG: Caveolae and caveolins. Curr Opin Cell Biol 1996, 8:542-548.
41. Connell I, Agace W, Klemm P, Schembri M, Marild S, Svanborg C: Type 1 fimbrial expression enhances Escherichia coli virulence for the urinary tract Proc Natl Acad Sci USA 1996, 93:9827-9832.
42. Langermann S, Palaszynski S, Barnhart M, Auguste G, Pinkner JS, Burlein J, Barren P, Koenig S, Leath S, Jones CH, Hultgren SJ: Prevention of mucosal Escherichia coli infection by FimH-adhesin-based systemic vaccination. Science 1997, 276:607-611. The highly protective role of FimH protein of type 1 fimbriated E. coli in evoking protective immunity against experimental urinary tract infection in mice is demonstrated.
43. Thankavel K, Madison B, Ikeda T, Malaviya R, Shah AH, Arumugam PM, Abraham SN: Localization of a domain in the FimH adhesin of Escherichia coli type 1 fimbriae capable of receptor recognition and use of a domain-specific antibody to confer protection against experimental urinary tract infection. J Clin Invest 1997, 100:1123-1136. The protective role of antibodies against the functional domain within FimH in conferring protection against experimental urinary tract infection in mice is demonstrated. The mode of protection appears to be by blocking bacterial adherence to the urinary mucosa. A 100 amino acid residue stretch in FimH has been implicated in cell binding.
44. Soderhall M, Normark S, Ishikawa K, Karlsson K, Teneberg S, Winberg J, Mollby R: In duction of protective immunity after Escherichis coli bladder infection in primates. Dependence of the globoside-specific P-fimbrial tip adhesin and its cognate receptor J Clin Invest 1997, 100:364-372. The protective role of P fimbriae in conferring long lasting protection against ascending urinary tract infection in a primate model is described. In addition to serving as a potent immunogen, the PapG adhesin serves as a powerful adjuvant.
45. Mertz AJ, Rifenbery DB, Arvidson CG, So M: Type IV pili and maintenance of epithelial barrier function. Mol Med 1996, 2:745-754.